{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:58:14Z","timestamp":1786589894371,"version":"build-2736575974"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semperi.2025.152076","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:21:52Z","timestamp":1743391312000},"page":"152076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perinatal psychiatry: balancing maternal-fetal exposures to mental disorders and drug treatments"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-5212","authenticated-orcid":false,"given":"Anne M.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7186-1877","authenticated-orcid":false,"given":"Catherine S.","family":"Stika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3458-5986","authenticated-orcid":false,"given":"Katherine L.","family":"Wisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0058","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jmwh.12603","article-title":"Consensus Bundle on Maternal mental Health: perinatal depression and Anxiety","volume":"62","author":"Kendig","year":"2017","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.semperi.2025.152076_bib0115","unstructured":"Trost SL, Beauregard J, Njie F, et al. (2022). Pregnancy-related deaths: data from Maternal Mortality Review Committees in 36 US states, 2017\u20132019. Retrieved from Atlanta, GA."},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2013.87","article-title":"Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings","volume":"70","author":"Wisner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.semperi.2025.152076_bib0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression scale","volume":"150","author":"Cox","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10.1016\/j.semperi.2025.152076_bib0062","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.semperi.2025.152076_bib0008","series-title":"Diagnostic and Statistical Manual of Mental Disorders","article-title":"Depressive disorders","year":"2022"},{"issue":"10","key":"10.1016\/j.semperi.2025.152076_bib0105","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.semperi.2025.152076_bib0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10802-022-00911-7","article-title":"Associations between maternal stressful life events and perceived distress during pregnancy and child mental health at age 4","volume":"50","author":"Rudd","year":"2022","journal-title":"Res Child Adolesc Psychopathol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0132","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9244","article-title":"Association of elevated maternal psychological distress, altered fetal brain, and offspring cognitive and social-emotional outcomes at 18 months","volume":"5","author":"Wu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.semperi.2025.152076_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103545","article-title":"Neonatal and pregnancy complications following maternal depression or antidepressant exposure: A population-based, retrospective birth cohort study","volume":"84","author":"Su","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.semperi.2025.152076_bib0129","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2023.5648","article-title":"Prioritizing maternal mental health in addressing morbidity and mortality","author":"Wisner","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53626","article-title":"Structural racism, mass incarceration, and racial and ethnic disparities in severe maternal morbidity","volume":"7","author":"Hailu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.semperi.2025.152076_bib0036","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.2534-15.2016","article-title":"Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain","volume":"36","author":"Goeden","year":"2016","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1467-8624.2009.01385.x","article-title":"The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development","volume":"81","author":"Davis","year":"2010","journal-title":"Child Dev"},{"key":"10.1016\/j.semperi.2025.152076_bib0071","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-clinpsy-050718-095539","article-title":"Prenatal developmental origins of future psychopathology: mechanisms and pathways","volume":"15","author":"Monk","year":"2019","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.semperi.2025.152076_bib0002","article-title":"Association between maternal perinatal stress and depression on infant DNA methylation in the first year of life","author":"Abrishamcar","year":"2024","journal-title":"Res Sq"},{"key":"10.1016\/j.semperi.2025.152076_bib0064","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/bs.irn.2019.11.002","article-title":"Prenatal stress: effects on fetal and child brain development","volume":"150","author":"Lautarescu","year":"2020","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.semperi.2025.152076_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2023.3161","article-title":"Prenatal antidepressant exposure and offspring brain morphologic trajectory","author":"Koc","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.semperi.2025.152076_bib0092","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1038\/tp.2013.79","article-title":"Maternal anxiety and infants' hippocampal development: timing matters","volume":"3","author":"Qiu","year":"2013","journal-title":"Transl Psychiatry"},{"issue":"9","key":"10.1016\/j.semperi.2025.152076_bib0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaac.2022.03.021","article-title":"Associations of maternal prenatal stress and depressive symptoms with childhood neurobehavioral outcomes in the ECHO cohort of the NICHD fetal Growth Studies: fetal growth velocity as a potential mediator","volume":"61","author":"Babineau","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0056","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00737-016-0624-6","article-title":"Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy study","volume":"19","author":"Karam","year":"2016","journal-title":"Arch Womens Ment Health"},{"issue":"13","key":"10.1016\/j.semperi.2025.152076_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132876","article-title":"The role of choline in neurodevelopmental disorders-A narrative review focusing on ASC, ADHD and dyslexia","volume":"15","author":"Derbyshire","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0098","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/appi.ajp.2015.15091188","article-title":"Perinatal phosphatidylcholine supplementation and early childhood behavior problems: evidence for CHRNA7 moderation","volume":"173","author":"Ross","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2024.3982","article-title":"Neuropsychological outcomes in 6-year-old children of women with epilepsy: A prospective nonrandomized clinical trial","volume":"82","author":"Meador","year":"2025","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0074","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/advances\/nmy120","article-title":"The importance of maternal folate status for brain development and function of offspring","volume":"10","author":"Naninck","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1016\/j.semperi.2025.152076_bib0117","article-title":"Neonatal outcomes in the MONEAD study of pregnant women with epilepsy","volume":"7","author":"Van Marter","year":"2021","journal-title":"J Pediatr X"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0084","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after In utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0113","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/epi4.12420","article-title":"Global Survey of Guidelines for the Management of Epilepsy in Pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"5","author":"Tomson","year":"2020","journal-title":"Epilepsia Open"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0068","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1192\/bjo.2023.549","article-title":"Folic acid prescription and suicide attempt prevention: effect of past suicidal behaviour, psychiatric diagnosis and psychotropic medication","volume":"9","author":"Mann","year":"2023","journal-title":"BJPsych Open"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0057","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/AOG.0000000000000559","article-title":"Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial","volume":"124","author":"Keenan","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0079","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaac.2016.02.012","article-title":"Developmental effects of prenatal selective serotonin reuptake inhibitor exposure in perspective: are we comparing apples to apples?","volume":"55","author":"Oberlander","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0131","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1176\/appi.ajp.157.12.1933","article-title":"Risk-benefit decision making for treatment of depression during pregnancy","volume":"157","author":"Wisner","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.semperi.2025.152076_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s44294-024-00008-0","article-title":"Antidepressant use during pregnancy and the risk of preterm birth \u2013 a cohort study","volume":"2","author":"Amit","year":"2024","journal-title":"npj Women's Health"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0066","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0112","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jamapsychiatry.2023.2664","article-title":"Maternal depression, prenatal SSRI exposure, and brain trajectories in childhood","volume":"80","author":"Talati","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0069","doi-asserted-by":"crossref","first-page":"250.e251","DOI":"10.1016\/j.ajog.2023.12.020","article-title":"Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence","volume":"231","author":"Mansour","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semperi.2025.152076_bib0004","unstructured":"Administration, U.S. Food & Drug. (2011b, December 13, 2011). FDA Drug Safety Communication: selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. Retrieved from https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-selective-serotonin-reuptake-inhibitor-ssri-antidepressant-use-during."},{"issue":"21","key":"10.1016\/j.semperi.2025.152076_bib0048","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0077","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jwh.2018.7319","article-title":"Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn: an update meta-analysis","volume":"28","author":"Ng","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2011","journal-title":"Am J Perinatol"},{"issue":"25","key":"10.1016\/j.semperi.2025.152076_bib0051","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.semperi.2025.152076_bib0065","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mayocpiqo.2023.02.002","article-title":"Poor neonatal adaptation after antidepressant exposure during the third trimester in a geographically defined cohort","volume":"7","author":"Brumbaugh","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0119","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14492","article-title":"Risk of poor neonatal adaptation syndrome among infants exposed to second-generation Atypical antipsychotics compared to antidepressants: results from the National Pregnancy Registry for psychiatric medications","volume":"84","author":"Viguera","year":"2023","journal-title":"J Clin Psychiatry"},{"issue":"19","key":"10.1016\/j.semperi.2025.152076_bib0072","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000516031","article-title":"Neonatal withdrawal syndrome following late in utero exposure to selective serotonin reuptake inhibitors: A systematic review and Meta-analysis of observational studies","volume":"90","author":"Wang","year":"2021","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0039","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.4088\/JCP.12r07967","article-title":"The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0059","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/apa.12921","article-title":"Risk factors for poor neonatal adaptation after exposure to antidepressants in utero","volume":"104","author":"Kieviet","year":"2015","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0078","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0019","doi-asserted-by":"crossref","first-page":"e2772","DOI":"10.1002\/hup.2772","volume":"36","author":"Colombo","year":"2021","journal-title":"Hum Psychopharmacol"},{"issue":"7","key":"10.1016\/j.semperi.2025.152076_bib0063","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.semperi.2025.152076_bib0101","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-024-01923-1","article-title":"Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect","author":"Salisbury","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semperi.2025.152076_bib0096","article-title":"Risks and benefits of pre-delivery taper in pregnant women taking antidepressants","author":"Robakis","year":"2023","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0123","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/ppe.12660","article-title":"Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage","volume":"34","author":"Palmsten","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0103","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/15299732.2016.1267685","article-title":"Acute dissociative reaction to spontaneous delivery in a case of total denial of pregnancy: diagnostic and forensic aspects","volume":"18","author":"Sar","year":"2017","journal-title":"J Trauma Dissociation"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0047","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1176\/appi.ajp.2012.11091365","article-title":"Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating","volume":"169","author":"Hunter","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0111","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamainternmed.2022.4268","article-title":"Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children","volume":"182","author":"Suarez","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0106","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/cpt.2746","article-title":"Changes in sertraline plasma concentrations across pregnancy and postpartum","volume":"112","author":"Stika","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semperi.2025.152076_bib0107","doi-asserted-by":"crossref","unstructured":"Stika, Catherine S., Avram, Michael J., George Jr., Alfred L., Yang, Amy, Ciolino, Jody D., Venkataramanan, Raman, Wisner, Katherine L.. (2024). Changes in S-citalopram plasma concentrations across pregnancy and postpartum. [Manuscript Submitted for Publication].","DOI":"10.1002\/cpt.3642"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/JCP.0000000000001821","article-title":"Concentrations of fluoxetine enantiomers decline during pregnancy and increase after birth","volume":"44","author":"Wisner","year":"2024","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00737-016-0707-4","article-title":"Treatment options for hyperemesis gravidarum","volume":"20","author":"Abramowitz","year":"2017","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0032","first-page":"27","article-title":"Cannabis hyperemesis syndrome in a recently abstinent chronic user: assessment and intervention","volume":"5","author":"Ei Sherif","year":"2024","journal-title":"Consort Psychiatr"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0011","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0034","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0082","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/acps.13431","article-title":"Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study","volume":"145","author":"Ostenfeld","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"10.1016\/j.semperi.2025.152076_bib0030","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","article-title":"Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes","volume":"67","author":"Djulus","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.euroneuro.2015.06.014","article-title":"Mirtazapine in pregnancy and lactation - A systematic review","volume":"26","author":"Smit","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0016","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0099","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12417","article-title":"Trends in risk of pregnancy loss among US women, 1990-2011","volume":"32","author":"Rossen","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0037","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18r12412","article-title":"Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis","volume":"80","author":"Grigoriadis","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0038","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/0706743720904860","article-title":"Pregnancy and delivery outcomes following benzodiazepine exposure: A systematic review and meta-analysis","volume":"65","author":"Grigoriadis","year":"2020","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0122","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/clpt.2010.97","article-title":"Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy","volume":"88","author":"Wang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5860","article-title":"Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway","volume":"3","author":"Huitfeldt","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.semperi.2025.152076_bib0052","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9378(71)90282-1","article-title":"Placental transer and fetal metabolism of diazepam in early human pregnancy","volume":"109","author":"Idanpaan-Heikkila","year":"1971","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0067","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cpt1975175564","article-title":"Placental transfer to diazepam and its disposition in the newborn","volume":"17","author":"Mandelli","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.43282","article-title":"Association of prenatal exposure to benzodiazepines with development of Autism spectrum and Attention-Deficit\/Hyperactivity disorders","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0133","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/JME-21-0155","article-title":"Effects of melatonin on the production of GnRH and LH in luteal cells of pregnant sows","volume":"68","author":"Zhang","year":"2022","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmt054","article-title":"Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology","volume":"20","author":"Reiter","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.semperi.2025.152076_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339304","article-title":"Melatonin: the placental antioxidant and anti-inflammatory","volume":"15","author":"Joseph","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.semperi.2025.152076_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108534","article-title":"Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome","volume":"124","author":"Reiter","year":"2024","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0033","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370304800207","article-title":"A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy","volume":"48","author":"Einarson","year":"2003","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/JCP.0000000000001630","article-title":"Reproductive safety of Trazodone after maternal exposure in early pregnancy: A comparative ENTIS cohort study","volume":"43","author":"Dao","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0083","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jcph.2111","article-title":"Dosage optimization of Lamotrigine in pregnancy: A pharmacometric approach using modeling and simulation","volume":"62","author":"Pa","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0086","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy outcomes following In utero exposure to Lamotrigine: A systematic review and meta-analysis","volume":"31","author":"Pariente","year":"2017","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0021","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","article-title":"Lamotrigine and the risk of malformations in pregnancy","volume":"64","author":"Cunnington","year":"2005","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.semperi.2025.152076_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.1058","article-title":"Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study","volume":"109","author":"Diav-Citrin","year":"2017","journal-title":"Birth Defects Research"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0061","first-page":"441","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"issue":"26","key":"10.1016\/j.semperi.2025.152076_bib0075","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/0024-3205(81)90541-5","article-title":"A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations","volume":"29","author":"Nau","year":"1981","journal-title":"Life Sci"},{"issue":"42","key":"10.1016\/j.semperi.2025.152076_bib0013","first-page":"565","article-title":"Valproic acid and spina bifida: a preliminary report\u2013France","volume":"31","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8304","key":"10.1016\/j.semperi.2025.152076_bib0097","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0080","first-page":"119","article-title":"The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0042","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pds.5573","article-title":"Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida","volume":"32","author":"Haug","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semperi.2025.152076_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109219","article-title":"Specific fetal malformations following intrauterine exposure to antiseizure medication","volume":"142","author":"Vajda","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0127","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jmg.24.11.692","article-title":"Fetal valproate syndrome: is there a recognisable phenotype?","volume":"24","author":"Winter","year":"1987","journal-title":"J Med Genet"},{"key":"10.1016\/j.semperi.2025.152076_bib0009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2019.01.038","article-title":"Risk of autistic spectrum disorder in offspring with parental mood disorders: A systematic review and meta-analysis","volume":"248","author":"Ayano","year":"2019","journal-title":"J Affect Disord"},{"issue":"12","key":"10.1016\/j.semperi.2025.152076_bib0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2309359","article-title":"Risk of autism after prenatal topiramate, Valproate, or lamotrigine exposure","volume":"390","author":"Hernandez-Diaz","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25570","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones","volume":"3","author":"Daugaard","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/AOG.0000000000004893","article-title":"Valproate teratogenicity: A moving target","volume":"140","author":"Gruppuso","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0006","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24f15432","article-title":"Epilepsy, antiepileptic drugs, and adverse pregnancy outcomes, 2: major congenital malformations with antiepileptic drug monotherapy","volume":"85","author":"Andrade","year":"2024","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0089","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","article-title":"Differential effects of antiepileptic drugs on neonatal outcomes","volume":"24","author":"Pennell","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.semperi.2025.152076_bib0054","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study","volume":"341","author":"Jentink","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0081","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.75.6.517","article-title":"Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy","volume":"75","author":"Ornoy","year":"1996","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0118","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"Veiby","year":"2014","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0044","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.semperi.2025.152076_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003322","article-title":"Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset","volume":"17","author":"Patorno","year":"2020","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.semperi.2025.152076_bib0031","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40264-023-01307-2","article-title":"Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries","volume":"46","author":"Dudukina","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.semperi.2025.152076_bib0015","series-title":"Lithium","author":"Chokhawala","year":"2024"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0124","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/bjp.bp.116.192799","article-title":"Lithium dosing strategies during pregnancy and the postpartum period","volume":"211","author":"Wesseloo","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0076","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy","volume":"162","author":"Newport","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.semperi.2025.152076_bib0027","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1176\/appi.ajp.2014.12111402","article-title":"Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study","volume":"171","author":"Diav-Citrin","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib134","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/jcm9061819","article-title":"Lithium use during pregnancy and the risk of miscarriage","volume":"9","author":"Poels","year":"2020","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.semperi.2025.152076_bib0073","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(18)30180-9","article-title":"Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies","volume":"5","author":"Munk-Olsen","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"8792","key":"10.1016\/j.semperi.2025.152076_bib0053","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0140-6736(92)90346-5","article-title":"Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester","volume":"339","author":"Jacobson","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0091","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bdi.13133","article-title":"The effect of prenatal lithium exposure on the neuropsychological development of the child","volume":"24","author":"Poels","year":"2022","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bdi.13297","article-title":"Brain development after intrauterine exposure to lithium: A magnetic resonance imaging study in school-age children","volume":"25","author":"Poels","year":"2023","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.semperi.2025.152076_bib0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cpt.770","article-title":"Treatment with antipsychotics in pregnancy: changes in drug disposition","volume":"103","author":"Westin","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.semperi.2025.152076_bib0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0108","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","article-title":"Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: A national birth cohort study","volume":"182","author":"Straub","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.semperi.2025.152076_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euroneuro.2024.03.003","article-title":"Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: systematic review and network meta-analysis","volume":"83","author":"Wang","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152076_bib0088","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5498\/wjp.v14.i4.582","article-title":"Outcomes of long-acting injectable antipsychotics use in pregnancy: A literature review","volume":"14","author":"Pejcic","year":"2024","journal-title":"World J Psychiatry"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0093","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20ac13597","article-title":"Long-acting injectable antipsychotic use during pregnancy: A brief review and concise guide for clinicians","volume":"81","author":"Reinstein","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.semperi.2025.152076_bib0003","unstructured":"Administration, U.S. Food & Drug. (2011a). FDA Drug Safety Communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-antipsychotic-drug-labels-updated-use-during-pregnancy-and-risk."},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061328","article-title":"Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study","volume":"12","author":"Heinonen","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.semperi.2025.152076_bib0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00228-022-03428-6","article-title":"Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010-2019","volume":"79","author":"Cohen","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.semperi.2025.152076_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43648","article-title":"Methylphenidate and atomoxetine in pregnancy and possible adverse fetal outcomes: A systematic review and meta-analysis","volume":"7","author":"di Giacomo","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.semperi.2025.152076_bib0049","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2017.3644","article-title":"Association between methylphenidate and amphetamine use in Pregnancy and risk of congenital malformations: A cohort Study from the International Pregnancy Safety Study Consortium","volume":"75","author":"Huybrechts","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.semperi.2025.152076_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jamapsychiatry.2023.5073","article-title":"Prescription stimulant use during pregnancy and risk of neurodevelopmental disorders in children","volume":"81","author":"Suarez","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.semperi.2025.152076_bib0114","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/AOG.0000000000005202","article-title":"Treatment and management of mental health conditions during pregnancy and postpartum: ACOG Clinical Practice Guideline No. 5","volume":"141","year":"2023","journal-title":"Obstet Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T01:22:04Z","timestamp":1749604924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000525000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0146000525000539"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152076","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal psychiatry: balancing maternal-fetal exposures to mental disorders and drug treatments","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152076"}}